Close
Open Nav
2018 Participating Investors

Below is a representative list of participating investment firms and sell side research analysts for the 2018 BIO Investor Forum.*

AbbVie
AbbVie Ventures
ABES Venture Partners
Abingworth Management
Agent Capital
Agilent Technologies
Altamont Pharmaceutical Holdings
aMoon Fund
AngelMD
ARCH Venture Partners
Asajes Ventures
Aspire Capital Partners
Asset Management Ventures
Astellas Innovation Management
Astellas Venture Management
ATEL Ventures
ATEM Capital
AuGC BioFund LP
Bay City Capital
Berkeley Catalyst Fund
BGI Venture
Bill and Melinda Gates Foundation Venture Capital
BioPacific Investors
Bios Partners
BioSense Global
Biotech Alliances International
BOSON Capital Partners
Brace Pharma Capital
Brain Trust
Brandon Capital Partners
Bridge Bank
Canaan Partners
Canadian Imperial Bank of Commerce
Capital IP
C-Bridge Capital
CH Innovations
CID4
Codon Capital
Columbia Threadneedle Investments
Crosswave Management
CRV
CSC Leasing
DEFTA Partners
Dorset Capital
Dorset Capital and Par Equity USA
Dynamk Capital
East West Bank
EDB Investments
Efung Capital
Emerson Collective
ESC Advisors
Esperante
EWB
Excelyrate Capital
Finance Technology Leverage
First Republic Bank
Five Corners Capital
FMG Ventures
Fortress Biotech
Frazier Healthcare Partners
GE Ventures
Genesys Capital Partners
Genoa Ventures
GPB Capital
Grey Sky Venture Partners
HealthCare Royalty Partners
Helicase Venture
Hemi Ventures
Horizon Technology Finance
Illumina Ventures
Innovation Endeavors
Innovation Network Corporation of Japan
IPF Partners
JAFCO Co.
JDRF T1D Fund
Johnson & Johnson Innovation Center
Joyance Partners
Life Science Angels
Lilly Asia Ventures
Lincoln Park Capital
Locust Walk
Lyfe Capital

 

Matthews Asia
Maxpro Ventures
MBL Venture Capital Co.
Medpro Investors
Medstartr Ventures
Merieux Developpement
Militia Hill Ventures
Mission Bay Capital
Mitsui & Co. Global Investment
MP Healthcare Venture Management
MPM Capital
MyBioGate
Nan Fung Life Sciences
NanoDimension
NEA
Novo Ventures
Oceaniq Capital Partners
OCV
OmniCyte
Opus Point Partners
Oresund Capital
Osage University Partners
OSF Healthcare Ventures
Otsuka Pharmaceutical
Oxford Finance
Palo Alto Investors
Panacea Venture Heathlcare
Pangaea Ventures
Pathway BioVentures
Pivotal bioVenture Partners
PoC Capital
Premier Partners
Presidio Partners
Prevail Partners
Qiming US Healthcare Ventures
Quantum Capital Management
Quark Venture
RBV Capital
Red Tailed Hawk Venture Partners
Relentless Pursuit Partners
Remiges Ventures
Roche
Roche Venture Fund
RTP Capital
Salubris Pharma
Samsara BioCapital
Santen Pharmaceutical Co.
Satter Medical Technology Partnership
SBA
Silicon Valley Bank
Sofinnova Ventures
Solar Capital
SR One
Surveyor Capital
Syzygy Therapeutics
Taiho Ventures
Taiwania Capital
Terra Magnum Capital Partnership
The Brain Trust Accelerator Fund
The Engine
The Leukemia & Lymphoma Society
Thiel Capital
Tosoh USA
TransPacific Venture Capital Partners
Trinitas Capital
UCSF
University of Stirling
US Angels
venBio Partners
Ventac Partners
Versant Ventures
Viking Global Investors
Vivo Capital
W Global Capital/International Capital Management
WBB Securities
Westlake Ventures
WestPark Capital
WI Harper Group
Xeraya Capital Life Venture
Yonjin Capital
YStrategies

 

*As of 9/19/2018